v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:      
Net income $ 1,523,293 $ 1,400,723 $ 1,020,951
Adjustment to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 201,342 198,473 176,870
Amortization of right-of-use assets 42,810 37,338 39,339
Stock-based compensation costs (note 10) 104,348 91,661 80,184
(Gain) loss attributable to equity method investments, net of dividends received (note 6) (2,382) (3,644) 1,848
(Gain) loss on equity investments (note 6) 15,014 10,299 4,045
Gain on previously held equity investment (note 6) (4,353) 0 0
Restructuring expenses (note 17) 0 0 33,239
Changes in operating assets and liabilities:      
Accounts receivable (96,778) (76,684) (134,278)
Inventories (9,920) (80,165) 172,203
Prepaid expenses, net deferred income taxes and other current assets (140,260) 82,629 (115,213)
Accounts payable, accrued expenses and other 172,715 90,958 122,072
Net cash provided by (used in) operating activities 1,805,829 1,751,588 1,401,260
Cash flows from investing activities:      
Purchases of property, plant and equipment (156,285) (89,865) (99,460)
Patent registration costs (18,670) (10,777) (15,396)
Purchases of intangible assets (2,218) 0 0
Business acquisitions, net of cash acquired (350,724) (139,248) (133,464)
Purchases of investments (note 6) (28,536) (6,416) (12,765)
Proceeds from exits of investments (note 6) 2,752 4,628 1,000
Proceeds (payments) on maturity of foreign currency contracts 8,482 41,633 (9,699)
Net cash provided by (used in) investing activities (545,199) (200,045) (269,784)
Cash flows from financing activities:      
Proceeds from issuance of common stock, net 74,503 74,439 53,094
Taxes paid related to net share settlement of equity awards (21,833) (18,077) (8,757)
Purchases of treasury stock (700,037) (300,025) (150,011)
Payments of business combination contingent consideration 0 (855) (1,293)
Acquisition of consolidated subsidiary 0 (10,855) 0
Proceeds from borrowings, net of borrowing costs 0 0 105,000
Repayment of borrowings (10,000) (40,000) (835,000)
Dividends paid (349,662) (310,880) (282,320)
Net cash provided by (used in) financing activities (1,007,029) (606,253) (1,119,287)
Effect of exchange rate changes on cash 6,183 25,799 (1,719)
Net increase (decrease) in cash and cash equivalents 259,784 971,089 10,470
Cash and cash equivalents at beginning of period 1,209,450 238,361 227,891
Cash and cash equivalents at end of period 1,469,234 1,209,450 238,361
Supplemental disclosure of cash flow information:      
Income taxes paid, net of refunds 357,167 214,013 278,400
Interest paid 27,057 28,415 45,708
Fair value of assets acquired, excluding cash 151,186 43,534 46,033
Liabilities assumed (11,841) (6,279) (7,696)
Goodwill on acquisition 222,933 101,323 92,191
Previously held equity investment (7,353) 0 0
Deferred payments (1,030) 670 (143)
Fair value of contingent consideration (3,171) 855 4,372
Cash paid for acquisitions $ 350,724 $ 140,103 $ 134,757